Status of vaccine research and development of vaccines for GBS
Author:
Open Access
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infantsVaccine, 2013
- Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccinesVaccine, 2012
- Invasive Group B Streptococcal Infection in Infants, MalawiEmerging Infectious Diseases, 2007
- Association between low concentrations of antibodies to protein α and Rib and invasive neonatal group B streptococcal infectionArchives of Disease in Childhood - Fetal and Neonatal Edition, 2006
- Immune Response of Healthy Women to 2 Different Group B Streptococcal Type V Capsular Polysaccharide–Protein Conjugate VaccinesThe Journal of Infectious Diseases, 2004
- Safety and Immunogenicity of a Bivalent Group B Streptococcal Conjugate Vaccine for Serotypes II and IIIThe Journal of Infectious Diseases, 2003
- Effects of Alum Adjuvant or a Booster Dose on Immunogenicity during Clinical Trials of Group B Streptococcal Type III Conjugate VaccinesInfection and Immunity, 2001
- Safety and Immunogenicity of Capsular Polysaccharide–Tetanus Toxoid Conjugate Vaccines for Group B Streptococcal Types Ia and IbThe Journal of Infectious Diseases, 1999
- Immunization of Pregnant Women with a Polysaccharide Vaccine of Group B StreptococcusNew England Journal of Medicine, 1988
- TWO SEROLOGICAL TYPES OF GROUP B HEMOLYTIC STREPTOCOCCI WITH RELATED, BUT NOT IDENTICAL, TYPE-SPECIFIC SUBSTANCESJournal of Experimental Medicine, 1938